NatureWell to Attend Natural Products Expo West
SAN DIEGO, March 7 /PRNewswire-FirstCall/ — NatureWell, Incorporated (BULLETIN BOARD: NAWL) , is pleased to announce that it will attend the Natural Products Expo West trade show (“Expo West”) (http://www.expowest.com/) as an exhibitor, in Anaheim, California, March 8-11, 2007.
Named one of the 50 fastest growing trade shows in the country by TradeShow Weekly, Natural Products Expo West attracted more than 43,000 industry members last year. This year’s show will feature more than 2,700 exhibits in the areas of natural and organic foods, healthy ethnic and specialty foods, supplements, health & beauty and natural living products.
NatureWell’s attendance and presentation at Expo West will focus on the continued expansion of the Company’s reseller distribution network for MigraSpray(R), its homeopathic medicine for the prevention and treatment of migraine headaches, that includes independent health food stores, pharmacies offering natural medicine, medical doctors, osteopathic doctors, chiropractic doctors and naturopathic doctors. The show will also provide an opportunity to continue branding and growing awareness of MigraSpray among individuals who suffer with migraine and those who are interested in the benefits of natural medicine.
“As one of the largest trade shows specifically catering to natural products, Expo West presents a unique opportunity for the Company to reach out to the decision makers of independent retailers, healthcare professionals and consumers,” commented Mr. James Arabia, NatureWell, Incorporated’s Chairman and Chief Executive Officer. “Expo West is a very large venue that promises to provide a dynamic atmosphere that we believe will allow the Company to develop relationships and acquire highly qualified sales leads in the natural healthcare field from which we may generate sales and establish accounts.”
About NatureWell, Incorporated:
NatureWell, Incorporated (http://www.naturewell.com/) is an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products. The Company currently markets its flagship product MigraSpray (http://www.migraspray.com/), a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management’s beliefs and assumptions regarding information currently available, and are made pursuant to the “safe harbor” provisions of the federal securities laws. The Company’s actual performance and results could differ materially from those expressed in the forward- looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company’s actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company’s ability to secure adequate financing, the Company’s ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company’s products or of the supplies or ingredients used to manufacture the Company’s products, the effectiveness of the Company’s products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company’s ability to anticipate changes in the market. These and other potential risks and uncertainties are set forth in the Company’s filings with the Securities & Exchange Commission. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
NatureWell, Incorporated
CONTACT: James R. Arabia, Chairman and CEO of NatureWell, Incorporated,+1-800-454-6790
Web site: http://www.naturewell.com/http://www.migraspray.com/